Danaher vs Novo Nordisk
Danaher (DHR), health care, and Novo Nordisk (NVO), health care, side by side on market value, valuation, margins, balance sheet and price change. Higher and lower are marked; neither is called better.
Novo Nordisk is worth $179.2B on the stock market and Danaher $159.5B: Novo Nordisk is valued at 12% more. Danaher trades at 37.5 times earnings and Novo Nordisk at 10.3; operating margins in their latest fiscal years were 19.1% and 41.3%. Over the past year Danaher's share price has moved +1.95% and Novo Nordisk's -12.5%.
Key facts
- Danaher market value
- $159.5B
- Novo Nordisk market value
- $179.2B
- Danaher P/E
- 37.5
- Novo Nordisk P/E
- 10.3
- Danaher revenue
- $24.6BFY to 2025-12-31
- Novo Nordisk revenue
- $45.9BFY to 2025-12-31
- Superinvestors holding both
- 2
Market values as of .
| Measure | Danaher | Novo Nordisk |
|---|---|---|
| Sector | Health Care | Health Care |
| Country | ||
| Fiscal year ends | 2025-12-31 | 2025-12-31 |
| Size | ||
| Market cap | $159.5Blower | $179.2Bhigher |
| Revenue | $24.6Blower | $45.9Bhigher |
| Earnings | $3.6Blower | $15.2Bhigher |
| Employees | 58,000lower | 68,794higher |
| Total assets | $83.5Bhigher | $80.6Blower |
| Valuation | ||
| P/E | 37.5higher | 10.3lower |
| P/S | 6.5higher | 3.9lower |
| P/B | 3.0 | — |
| Dividend yield | 0.66% | — |
| Profitability | ||
| Operating margin | 19.1%lower | 41.3%higher |
| Balance sheet | ||
| Net assets | $52.5Bhigher | $28.8Blower |
| Total liabilities | $30.9Blower | $51.8Bhigher |
| Total debt | $18.4Blower | $19.4Bhigher |
| Cash on hand | $4.6Bhigher | $3.9Blower |
| Price change | ||
| Today | -1.41%higher | -2.26%lower |
| 1 year | +1.95%higher | -12.5%lower |
Market value, P/E, P/B, dividend yield and price changes are from live quotes (Yahoo Finance; prices may be delayed 15 minutes or more). Revenue, earnings, operating margin and the balance-sheet figures are from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day. P/S sets today's market value against the latest fiscal year's revenue. “Higher” and “lower” compare the two numbers only; a higher P/E or more debt is not better. Dividend yield and P/B are shown only for companies based in the US. A dash means no figure is on file.
Which superinvestors hold them
From each tracked investor's latest 13F filing. A 13F lists long positions in US-listed shares at a quarter end, filed up to 45 days later.
Both (2)
- Dodge & Cox team1.2% / 0.4%
- Ken Fisher0.3% / 0.1%
Danaher only (17)
- Wallace Weitz7.0%
- Eric Bannasch4.8%
- Larry Robbins4.4%
- Doug Silverman2.3%
- Dan Loeb2.2%
- Daniel Sundheim2.1%
- Brandon Haley1.6%
- Steven Romick1.5%
- Chase Coleman0.4%
- Israel Englander0.3%
- Primecap team0.3%
- Louis Bacon0.2%
- Stanley Druckenmiller0.2%
- Bill Gates0.2%
- Cliff Asness0.2%
- Rajiv Jain<0.1%
- Bill Nygren<0.1%
Novo Nordisk only (6)
Percentages are each holding's share of that investor's reported portfolio (under "Both": Danaher / Novo Nordisk). Who owns DHR · Who owns NVO
More on Danaher
Further comparisons
Danaher against its closest peers
Novo Nordisk against its closest peers
Learn
Questions and answers
Which is bigger, Danaher or Novo Nordisk?
By market value, Novo Nordisk is the larger: $179.2B against $159.5B for Danaher. By revenue in its latest fiscal year, Novo Nordisk is the larger: $45.9B against $24.6B for Danaher.
Which has the higher P/E ratio?
Danaher: 37.5, against 10.3 for Novo Nordisk. A higher P/E means the market pays more for each dollar of the last twelve months' earnings; on its own it does not say which is the better value.
Which has the higher operating margin?
Novo Nordisk: 41.3%, against 19.1% for Danaher. Operating margin is operating income as a share of revenue in the latest fiscal year.
Which has more debt?
Novo Nordisk: $19.4B, against $18.4B for Danaher. Total debt is borrowings at the end of the latest fiscal year, as each company reported it; it is not set against cash here.
Which superinvestors own both Danaher and Novo Nordisk?
In their latest 13F filings, Dodge & Cox team and Ken Fisher hold both.
Cite this page
Funkfolio, “Danaher vs Novo Nordisk”, data as of 17 November 2026. https://funkfolio.com/compare/dhr-vs-nvo
Underlying data: Yahoo Finance quotes; SEC annual reports collected 2026-11-12; 13F filings.